Telomerase activity in human renal cell carcinoma

International Journal of Urology

Volumn 7, Issue 1, 2000, Pages 16-21

  Fujioka, Tomoaki ^a   Hasegawa, Michihiko ^a   Suzuki, Yasushi ^a   Suzuki, Tohru ^a   Sugimura, Jun ^a   Tanji, Susumu ^a   Koike, Hiroyuki ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Immunosuppressive acidic protein; Renal cell carcinoma; Telomerase activity; Telomeric repeat amplification protocol assay; Tumor grade.

Indexed keywords

DNA; IMMUNOSUPPRESSIVE ACID PROTEIN; TELOMERASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYMATIC ASSAY; ENZYME ACTIVITY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY PARENCHYMA; MALE; PLOIDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; TISSUE SECTION; TUMOR VOLUME;

AGED; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS; TELOMERASE;

EID: 0034020903     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2042.2000.00130.x     Document Type: Article

References (25)

1. Mehle C, Ljungberg B, Roos G. Telomere shortening in renal cell carcinoma. Cancer Res. 1994; 54: 236-41.
2. Zakian VA. Telomeres: Beginning to understand the end. Science 1995; 270: 1601-7.
3. Feng J, Funk WD, Wang SS et al. The RNA component of human telomerase. Science 1995; 269: 1236-41.
4. Kim NW, Piatyszek MA, Prowse KR et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-15.
5. Counter CM, Hirte HW, Bacchetti S, Harley CB. Telomerase activity in human ovarian carcinoma. Proc. Natl Acad. Sci. USA 1994; 91: 2900-4.
6. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW. Correlating telomerase activity levels with human neuroblastoma outcomes. Nature Med. 1995; 1: 249-55.
7. Chadeneau C, Hay K, Hirte HW, Gallinger S, Bacchetti S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res. 1995; 55: 2533-6.
8. Hiyama E, Yokoyama T, Tatsumoto N et al. Telomerase activity in gastric cancer. Cancer Res. 1995; 55: 3258-62.
9. Hiyama E, Gollahon L, Kataoka T et al. Telomerase activity in human breast tumors. J. Natl Cancer Inst. 1996; 88: 116-22.
10. Lin Y, Miyamoto H, Fujinami K et al. Telomerase activity in human bladder cancer. Clin. Cancer Res. 1996; 2: 929-32.
11. Lin Y, Uemura H, Fujinami K, Hosaka M, Harada M, Kubota Y. Telomerase activity in primary prostate cancer. J. Urol. 1997; 157: 1161-5.
12. Satomi Y. Current status of treatment of renal cell carcinoma and future problems. Jpn. J. Urol. 1990; 81: 1-13.
13. Tamura K, Shibata Y, Matsuda Y, Ishida N. Isolation and characterization of an immunosuppressive acidic protein from ascitic fluid of cancer patients. Cancer Res. 1981; 41: 3244-52.
14. Iizumi T, Yazaki T, Kanoh S et al. Circulating immune complexes and immunosuppressive acidic protein in patients with renal cell carcinoma. J. Urol. 1985; 135: 1097-100.
15. Ueda T. Serum immunosuppressive acidic protein in renal cell carcinoma. Urol. Res. 1986; 14: 101-3.
16. Igarashi T, Murakami S, Isaka S, Okano T, Shimazaki J, Matsuzaki O. Serum immunosuppressive acidic protein as a tumor maker for renal cell carcinoma. Eur. Urol. 1991; 19: 332-5.
17. Fujioka T, Ishikura K, Hasegawa M et al. Serum immunosuppressive acidic protein in renal cell carcinoma. Ann. Cancer Res. 1994; 3: 17-21.
18. Ljungberg B, Mehle C, Stenling R, Roos G. Heterogeneity in renal cell carcinoma and its impact on prognosis: A flow cytometric study. Br. J. Urol. 1996; 74: 123-7.
19. Mehle C, Piatyszek MA, Ljungberg B, Shay JW, Roos G. Telomerase activity in human renal cell carcinoma. Oncogene 1996; 13: 161-6.
20. Kinoshita H, Ogawa O, Mitsumori K, Kakei Y, Terachi T, Yoshida O. Low frequency of positive telomerase activity in a chromophobe subtype of renal cell carcinoma. J. Urol. 1998; 159: 245-51.
21. Rohde V, Sattler HP, Oehlenshlager B et al. Genetic changes and telomerase activity in human renal cell carcinoma. Clin. Cancer Res. 1988; 4: 198-202.
22. Japanese Urological Association, Japanese Society of Pathology and Japan Radiation Society. General Rules for Clinical and Pathological Studies on Renal Cell Carcinoma, 2nd edn. Kanehara Press, Tokyo, 1992.
23. Hiyama K, Hiyama E, Ishioka S et al. Telomerase activity in small-cell and non-small-cell lung cancers. J. Natl Cancer Inst. 1995; 87: 895-902.
24. Ramakrishnan S, Eppenberger U, Mueller H, Shinkai Y, Narayanan R. Expression profile of the putative catalytic subunit of the telomerase gene. Cancer Res. 1998; 58: 622-6.
25. Takakura M, Kyo S, Kanaya T, Tanaka M, Inoue M. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res. 1998; 58: 1558-61.